Our study revealed that GC with CLDN18-ARHGAP fusion could also activate PI3K-AKT-mTOR-FAS to enhance FFA production and promote Treg cells proliferation and survival in the TME by means of bioinformatic analysis, in vitro and in vivo experiments. The gene discussed is PIK3CA; the disease is gastric cancer.